Quality control ındicators for transurethral resection of none-muscle-ınvasive bladder cancer

Basit Öğe Kaydı
dc.contributor.authorAkand, Murat
dc.contributor.authorMuilwijk, Tim
dc.contributor.authorRaskin, Yannic
dc.contributor.authorDe Vrieze, Maxime
dc.contributor.authorJoniau, Steven
dc.contributor.authorVan der Aa, Frank
dc.date.accessioned2020-03-26T20:19:12Z
dc.date.available2020-03-26T20:19:12Z
dc.date.issued2019
dc.departmentSelçuk Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.description.abstractComplete transurethral resection of bladder tumor (TURBT) is the initial procedure of choice for nonemuscle-invasive bladder cancer, but its quality is far from optimal in clinical practice. We evaluated the existing body of evidence substantiating current quality control indicators (QCIs) for TURBT. A literature search was performed using PubMed and Embase, and selected articles were reviewed according to their level of evidence. Disease recurrence and progression were used as the primary end points. No hard evidence supports complete resection as a QCI, but rationally, it is the most important indicator for TURBT. A repeat resection is an important QCI in high-risk disease patients, but evidence suggests that it may not be necessary when detrusor muscle is present in the initial resection specimen. The presence of detrusor muscle in the resection specimen is a validated QCI for TURBT. Adjuvant intravesical instillation is a scientifically proven QCI. Bladder perforation is a controversial QCI in the existing literature. No evidence indicates the ideal time frame for the initial TURBT; thus, initial therapy in the first 6 weeks after diagnosis is not a good QCI. Three of the 6 proposed QCIs for TURBT are supported by evidence. Our literature analysis indicated the use of complete resection, repeat resection, the presence of detrusor muscle, and intravesical instillation are QCIs to minimize recurrence and progression, and increase beneficial outcomes.en_US
dc.identifier.citationAkand, M., Muilwijk, T., Raskin, Y., De Vrieze, M., Joniau, S.,Van Der Aa, F. (2019). Quality Control Indicators for Transurethral Resection of Non–Muscle-Invasive Bladder Cancer. Clinical genitourinary cancer, 17,(4), e784-e792.
dc.identifier.doi10.1016/j.clgc.2019.04.014en_US
dc.identifier.endpageE792en_US
dc.identifier.issn1558-7673en_US
dc.identifier.issn1938-0682en_US
dc.identifier.issue4en_US
dc.identifier.pmid31097388en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpageE784en_US
dc.identifier.urihttps://dx.doi.org/10.1016/j.clgc.2019.04.014
dc.identifier.urihttps://hdl.handle.net/20.500.12395/38142
dc.identifier.volume17en_US
dc.identifier.wosWOS:000476618100010en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorAkand, Murat
dc.language.isoenen_US
dc.publisherCIG MEDIA GROUP, LPen_US
dc.relation.ispartofCLINICAL GENITOURINARY CANCERen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectProgressionen_US
dc.subjectQuality indicatoren_US
dc.subjectQuality parameteren_US
dc.subjectRecurrenceen_US
dc.subjectTURBTen_US
dc.titleQuality control ındicators for transurethral resection of none-muscle-ınvasive bladder canceren_US
dc.typeReviewen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Murat Akand.pdf
Boyut:
261.25 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Full Text Access
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
Üroloji/Makale Koleksiyonu